Simmons Bed Supports 300 Million KRW Medical Expenses for Pediatric and Adolescent Patients

[Asia Economy Reporter Moon Hyewon] Simmons Bed announced on the 6th that it has signed a business agreement with Samsung Seoul Hospital to support pediatric and adolescent patients battling pediatric cancer and severe rare and intractable diseases.

Simmons Bed initiated this social contribution activity to alleviate the economic burden on patients who suffer additional hardships due to long-term treatment and to help them become independent, healthy members of society. The patients eligible for medical expense support are pediatric and adolescent patients up to 24 years old undergoing treatment at Samsung Seoul Hospital for pediatric cancer and severe rare and intractable diseases.

Simmons Bed plans to donate a total of 300 million KRW to Samsung Seoul Hospital to support inpatient treatment costs such as surgery and examinations, outpatient treatment costs including outpatient visits and tests, and the purchase of medical assistive devices such as wheelchairs and hearing aids.

Pediatric cancer is known as a disease with a significant economic burden due to the long treatment period averaging 2-3 years and high medical expenses. Due to low immunity and risk of infection, outdoor activities are restricted, and daily life activities such as attending school are also difficult, making support urgently needed.

Ahn Jeong-ho, CEO of Simmons Bed, said, “Amid the ongoing COVID-19 crisis putting all domestic medical facilities on high alert, we proceeded with this agreement to ensure that pediatric and adolescent patients in urgent need of help are not left behind.”

This content was produced with the assistance of AI translation services.